Feiya Yang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
- Urology top 5%
Papers in
- Surgery 23
- Bladder and Urothelial Cancer Treatments 18
- Urinary and Genital Oncology Studies 6
-
- Renal cell carcinoma treatment 8
- Prostate Cancer Treatment and Research 5
- Co-authors
- Nianzeng Xing (59 shared papers)Qinxin Zhao (14 shared papers)Xinxing Lu (5 shared papers)Mingshuai Wang (10 shared papers)Wenkuan Wang (9 shared papers)Lu Yin (5 shared papers)Sujun Han (15 shared papers)Dexi Chen (4 shared papers)
- Journals
- Advanced Materials (4 papers)Oncology Reports (3 papers)BMC Urology (3 papers)Frontiers in Oncology (3 papers)Cancer Management and Research (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Feiya Yang
66 papers receiving 1.6k citations
Feiya Yang's Hit Papers
Peers
Comparison fields: 5 of 91
- Cancer Research 289
- Urology 68
- Biochemistry 69
- Applied Microbiology and Biotechnology 20
- Molecular Medicine 51
Countries citing papers authored by Feiya Yang
This map shows the geographic impact of Feiya Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feiya Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feiya Yang more than expected).
Fields of papers citing papers by Feiya Yang
This network shows the impact of papers produced by Feiya Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feiya Yang. The network helps show where Feiya Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Feiya Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD‐L1 for Enhanced Cancer Immunotherapy Hit paper breakdown → | 2023 | 313 |
| 2 | 2020 | 165 | |
| 3 | 2020 | 87 | |
| 4 | 2015 | 81 | |
| 5 | 2023 | 73 | |
| 6 | 2018 | 73 | |
| 7 | 2019 | 68 | |
| 8 | 2019 | 62 | |
| 9 | 2019 | 62 | |
| 10 | 2015 | 58 | |
| 11 | 2023 | 53 | |
| 12 | 2015 | 52 | |
| 13 | 2022 | 36 | |
| 14 | 2023 | 30 | |
| 15 | 2018 | 25 | |
| 16 | 2022 | 22 | |
| 17 | 2023 | 21 | |
| 18 | 2018 | 21 | |
| 19 | 2020 | 20 | |
| 20 | 2016 | 16 |
About Feiya Yang
Feiya Yang is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Molecular Biology, Oncology and Cancer Research, having authored 71 papers that have together received 1.6k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (18 papers), Renal cell carcinoma treatment (8 papers), Nanoplatforms for cancer theranostics (7 papers), Epigenetics and DNA Methylation (6 papers), Urinary and Genital Oncology Studies (6 papers), Urinary Bladder and Prostate Research (5 papers), Prostate Cancer Treatment and Research (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Cancer Research (289 citations), Urology (68 citations), Biochemistry (69 citations), Applied Microbiology and Biotechnology (20 citations) and Molecular Medicine (51 citations). Feiya Yang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Nianzeng Xing, Qinxin Zhao, Xinxing Lu, Mingshuai Wang, Wenkuan Wang, Lu Yin, Sujun Han, Dexi Chen, Boda Guo and Haihua Xiao. Their work appears in journals such as Advanced Materials, Oncology Reports, BMC Urology, Frontiers in Oncology and Cancer Management and Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.